ReviewFrontiers in immunology2025
Immunomodulatory biomaterials for vascularized and innervated skeletal muscle repair.
Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The "Mechano-Metabolic-Immune" crosstalk within the skeletal muscle microenvironment: evolution of homeostatic remodeling and quality control mechanisms.Frontiers in immunology · 2026Review
- Biomimetic Scaffolds and Extracellular Matrix-Based Strategies for Myofiber Regeneration in Volumetric Muscle Loss.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The repair of functional innervated and vascularized skeletal muscle from severe injuries, such as critical limb ischemia, denervation, and volumetric muscle loss, remains a critical clinical challenge. Regenerative cell therapies are often hindered by donor site morbidities and rapid clearance from injured tissue. Furthermore, emerging tissue engineering and biomaterials approaches are often stifled by-and may even worsen-the chronic, inflammatory microenvironment that debilitates these sites of muscle injury, as well as the underlying peripheral nerves and microvessels. Consequently, the role of the immune system in tissue repair has been increasingly studied and capitalized upon in the design of regenerative biomaterials to overcome these challenges. In this review, recent strategies for the development of immunomodulatory biomaterials for vascularized and innervated skeletal muscle repair will be discussed within the context of muscle, nervous, and vascular tissues, as well as the respective roles of immune cells and tissue progenitors during these repair processes. These strategies span chemical functionalization, sustained presentation of immunomodulatory cues, and inflammatory responses to natural and synthetic biomaterials, among other approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.